These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

163 related items for PubMed ID: 19733005

  • 1. Targeting the 90 kDa heat shock protein improves photodynamic therapy.
    Ferrario A, Gomer CJ.
    Cancer Lett; 2010 Mar 28; 289(2):188-94. PubMed ID: 19733005
    [Abstract] [Full Text] [Related]

  • 2. Survivin, a member of the inhibitor of apoptosis family, is induced by photodynamic therapy and is a target for improving treatment response.
    Ferrario A, Rucker N, Wong S, Luna M, Gomer CJ.
    Cancer Res; 2007 May 15; 67(10):4989-95. PubMed ID: 17510430
    [Abstract] [Full Text] [Related]

  • 3. Pro-apoptotic and anti-inflammatory properties of the green tea constituent epigallocatechin gallate increase photodynamic therapy responsiveness.
    Ferrario A, Luna M, Rucker N, Wong S, Gomer CJ.
    Lasers Surg Med; 2011 Sep 15; 43(7):644-50. PubMed ID: 22057492
    [Abstract] [Full Text] [Related]

  • 4. Effects of HSP90 inhibitor 17-allylamino-17-demethoxygeldanamycin (17-AAG) on NEU/HER2 overexpressing mammary tumours in MMTV-NEU-NT mice monitored by Magnetic Resonance Spectroscopy.
    Rodrigues LM, Chung YL, Al Saffar NM, Sharp SY, Jackson LE, Banerji U, Stubbs M, Leach MO, Griffiths JR, Workman P.
    BMC Res Notes; 2012 May 23; 5():250. PubMed ID: 22621282
    [Abstract] [Full Text] [Related]

  • 5. Induction of prosurvival molecules during treatment: rethinking therapy options for photodynamic therapy.
    Gomer CJ.
    J Natl Compr Canc Netw; 2012 Oct 01; 10 Suppl 2():S35-9. PubMed ID: 23055213
    [Abstract] [Full Text] [Related]

  • 6. Heat Shock Protein 90 Inhibitor Decreases Collagen Synthesis of Keloid Fibroblasts and Attenuates the Extracellular Matrix on the Keloid Spheroid Model.
    Lee WJ, Lee JH, Ahn HM, Song SY, Kim YO, Lew DH, Yun CO.
    Plast Reconstr Surg; 2015 Sep 01; 136(3):328e-337e. PubMed ID: 26313837
    [Abstract] [Full Text] [Related]

  • 7. 17-AAG inhibits vemurafenib-associated MAP kinase activation and is synergistic with cellular immunotherapy in a murine melanoma model.
    Joshi SS, Jiang S, Unni E, Goding SR, Fan T, Antony PA, Hornyak TJ.
    PLoS One; 2018 Sep 01; 13(2):e0191264. PubMed ID: 29481571
    [Abstract] [Full Text] [Related]

  • 8. Antiangiogenic treatment enhances photodynamic therapy responsiveness in a mouse mammary carcinoma.
    Ferrario A, von Tiehl KF, Rucker N, Schwarz MA, Gill PS, Gomer CJ.
    Cancer Res; 2000 Aug 01; 60(15):4066-9. PubMed ID: 10945611
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of heat shock protein 90 impairs epidermal growth factor-mediated signaling in gastric cancer cells and reduces tumor growth and vascularization in vivo.
    Lang SA, Klein D, Moser C, Gaumann A, Glockzin G, Dahlke MH, Dietmaier W, Bolder U, Schlitt HJ, Geissler EK, Stoeltzing O.
    Mol Cancer Ther; 2007 Mar 01; 6(3):1123-32. PubMed ID: 17363505
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of heat shock protein 90 function by 17-allylamino-17-demethoxy-geldanamycin in Hodgkin's lymphoma cells down-regulates Akt kinase, dephosphorylates extracellular signal-regulated kinase, and induces cell cycle arrest and cell death.
    Georgakis GV, Li Y, Rassidakis GZ, Martinez-Valdez H, Medeiros LJ, Younes A.
    Clin Cancer Res; 2006 Jan 15; 12(2):584-90. PubMed ID: 16428504
    [Abstract] [Full Text] [Related]

  • 11. Therapeutic effects of radiolabeled 17-allylamino-17-demethoxygeldanamycin on human H460 nonsmall-cell lung carcinoma xenografts in mice.
    Sun J, Liu L, Jiang X, Chen D, Huang Y.
    Cancer Biother Radiopharm; 2010 Apr 15; 25(2):155-64. PubMed ID: 20423228
    [Abstract] [Full Text] [Related]

  • 12. 17-AAG improves cognitive process and increases heat shock protein response in a model lesion with Aβ25-35.
    Ortega L, Calvillo M, Luna F, Pérez-Severiano F, Rubio-Osornio M, Guevara J, Limón ID.
    Neuropeptides; 2014 Aug 15; 48(4):221-32. PubMed ID: 24819277
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. FLT3 expressing leukemias are selectively sensitive to inhibitors of the molecular chaperone heat shock protein 90 through destabilization of signal transduction-associated kinases.
    Yao Q, Nishiuchi R, Li Q, Kumar AR, Hudson WA, Kersey JH.
    Clin Cancer Res; 2003 Oct 01; 9(12):4483-93. PubMed ID: 14555522
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Celecoxib and NS-398 enhance photodynamic therapy by increasing in vitro apoptosis and decreasing in vivo inflammatory and angiogenic factors.
    Ferrario A, Fisher AM, Rucker N, Gomer CJ.
    Cancer Res; 2005 Oct 15; 65(20):9473-8. PubMed ID: 16230411
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Modulation of Hsp90 function in neurodegenerative disorders: a molecular-targeted therapy against disease-causing protein.
    Waza M, Adachi H, Katsuno M, Minamiyama M, Tanaka F, Doyu M, Sobue G.
    J Mol Med (Berl); 2006 Aug 15; 84(8):635-46. PubMed ID: 16741751
    [Abstract] [Full Text] [Related]

  • 19. Dimeric ansamycins--a new class of antitumor Hsp90 modulators with prolonged inhibitory activity.
    Zhang H, Yang YC, Zhang L, Fan J, Chung D, Choi D, Grecko R, Timony G, Karjian P, Boehm M, Burrows F.
    Int J Cancer; 2007 Feb 15; 120(4):918-26. PubMed ID: 17131314
    [Abstract] [Full Text] [Related]

  • 20. Targeted cancer therapy through 17-DMAG as an Hsp90 inhibitor: Overview and current state of the art.
    Mellatyar H, Talaei S, Pilehvar-Soltanahmadi Y, Barzegar A, Akbarzadeh A, Shahabi A, Barekati-Mowahed M, Zarghami N.
    Biomed Pharmacother; 2018 Jun 15; 102():608-617. PubMed ID: 29602128
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.